BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
CN Stock MarketDetailed Quotes
688238 Obio Technology
- 5.65
- -0.12-2.08%
Market Closed May 15 15:00 CST
3.67BMarket Cap-10.80P/E (TTM)
5.87High5.60Low118.89KlotVolume5.75Open5.77Pre Close67.86MTurnover1.85%Turnover RatioLossP/E (Static)649.04MShares6.8852wk High2.26P/B3.62BFloat Cap3.8652wk Low6.92Limit Up641.15MShs Float27.31Historical High4.62Limit Down4.68%Amplitude3.86Historical Low--Dividend TTM5.71Avg Price61.26KlotAsk--Div YieldTTM100Lot Size53.96KlotBid
Obio Technology Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -11.29%52.85M | 21.16%248.15M | 34.22%183.87M | 35.00%113.06M | 93.48%59.57M | -29.69%204.81M | -36.38%136.99M | -37.92%83.75M | -57.89%30.79M | 14.26%291.3M |
| Operating revenue | -11.29%52.85M | 21.16%248.15M | 34.22%183.87M | 35.00%113.06M | 93.48%59.57M | -29.69%204.81M | -36.38%136.99M | -37.92%83.75M | -57.89%30.79M | 14.26%291.3M |
| Total operating cost | -3.22%114.04M | 46.70%528.96M | 57.66%362.11M | 66.79%236.6M | 83.56%117.84M | 41.02%360.58M | 26.19%229.68M | 24.12%141.85M | 7.36%64.2M | 23.18%255.69M |
| Operating cost | -0.01%72.11M | 56.97%341.97M | 72.53%224.22M | 71.53%140.55M | 92.82%72.11M | 34.54%217.86M | 10.13%129.96M | 16.01%81.94M | 4.56%37.4M | 30.52%161.93M |
| Operating tax surcharges | 54.38%1.79M | 205.14%6.48M | 448.76%4.32M | 374.49%2.59M | 409.31%1.16M | 685.15%2.12M | 866.92%787.75K | 698.77%545.86K | 531.57%228.02K | 97.95%270.53K |
| Operating expense | -6.86%10.95M | 22.15%51.71M | 28.14%36.96M | 37.74%24.36M | 69.68%11.76M | 39.91%42.33M | 46.56%28.84M | 36.96%17.69M | 11.91%6.93M | 28.65%30.26M |
| Administration expense | -9.24%17.52M | 27.48%81.08M | 35.73%57.19M | 59.79%39.95M | 37.85%19.31M | 13.87%63.6M | 4.62%42.13M | -8.30%25M | 5.48%14.01M | 25.67%55.85M |
| Financial expense | 251.44%844.99K | 102.43%393.64K | 102.24%278.98K | 100.73%68.61K | 90.10%-557.97K | 40.99%-16.2M | 37.01%-12.46M | 12.72%-9.39M | -118.51%-5.64M | -234.13%-27.45M |
| -Interest expense (Financial expense) | -6.46%1.67M | 9.16%7.45M | 14.47%5.76M | 20.57%3.85M | 30.93%1.78M | 147.23%6.83M | 141.55%5.03M | 125.90%3.19M | 90.44%1.36M | -7.17%2.76M |
| -Interest Income (Financial expense) | 64.03%-843.16K | 68.32%-7.32M | 67.48%-5.71M | 68.61%-3.97M | 66.79%-2.34M | 23.95%-23.11M | 20.11%-17.56M | -3.67%-12.65M | -112.94%-7.06M | -170.19%-30.39M |
| Research and development | -23.00%10.82M | -6.95%47.33M | -3.13%39.15M | 11.54%29.08M | 24.70%14.05M | 46.06%50.87M | 70.20%40.42M | 83.95%26.07M | 58.80%11.27M | 47.47%34.83M |
| Credit Impairment Loss | -126.75%-308.25K | 149.12%522.77K | 130.84%525.02K | 148.92%649.91K | 1,612.03%1.15M | 62.90%-1.06M | 15.81%-1.7M | -33.95%-1.33M | 92.51%-76.22K | -667.79%-2.87M |
| Asset Impairment Loss | 126.15%146.22K | -317.37%-55.51M | -9,334.35%-27.3M | -999.01%-348.45K | -85.20%-559.13K | -7,098.22%-13.3M | 58.97%-289.42K | 113.20%38.76K | -292.39%-301.91K | 72.67%-184.76K |
| Adjustment items of total operating cost | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- | ---- | ---- |
| Other net revenue | ||||||||||
| Fair value change income | -387.02%-175.08K | 1,947.10%259.11K | ---- | ---- | --61K | 259.82%12.66K | --12.66K | --12.66K | ---- | ---7.92K |
| Invest income | 272.80%796.55K | 100.31%3.58K | -53.74%-1.3M | -28.19%-633.59K | -121.57%-460.95K | -150.80%-1.17M | -146.29%-846.66K | -258.75%-494.27K | -68.58%-208.04K | -35.37%2.3M |
| -Including: Investment income associates | 149.29%268.74K | 64.35%-820.57K | 15.21%-1.48M | -230.50%-812.41K | -266.96%-545.25K | -269.66%-2.3M | -333.20%-1.75M | -0.33%-245.81K | -20.40%-148.59K | 50.30%-622.63K |
| Asset deal income | -281.08%-55.66K | 5,703.45%5.9M | 3,959.43%5.9M | 287,398.14%1.08M | ---14.61K | --101.68K | --145.39K | ---376.85 | ---- | ---- |
| Other revenue | -76.15%1.7M | 21.78%19.18M | 52.07%11.69M | 96.33%9.51M | 377.22%7.15M | 129.90%15.75M | 97.97%7.69M | 84.51%4.84M | 9.07%1.5M | -37.09%6.85M |
| Operating profit | -16.00%-59.09M | -99.72%-310.45M | -115.26%-188.74M | -105.84%-113.28M | -56.76%-50.93M | -472.70%-155.45M | -341.54%-87.68M | -347.23%-55.03M | -341.07%-32.49M | -31.40%41.71M |
| Add:Non operating Income | -100.00%0.11 | -75.89%23.97K | -26.06%23.97K | 103.17%23.97K | 894,204.10%23.97K | 27.65%99.42K | 16.39%32.42K | -55.49%11.8K | -99.99%2.68 | -39.88%77.88K |
| Less:Non operating expense | 6,808.53%398.24K | 756.09%2.2M | 7,883.00%140.93K | 6,183.61%110.93K | 226.54%5.76K | 58.90%257.02K | -84.96%1.77K | 920.43%1.77K | 920.43%1.77K | 14.06%161.75K |
| Total profit | -16.83%-59.48M | -100.91%-312.63M | -115.47%-188.85M | -106.03%-113.36M | -56.69%-50.92M | -473.83%-155.6M | -341.35%-87.65M | -346.90%-55.02M | -340.61%-32.49M | -31.52%41.62M |
| Less:Income tax cost | 100.30%26.25K | 134.38%9.56M | 108.39%1.4M | 102.30%237.65K | -1,151.49%-8.62M | -1,273.69%-27.79M | -792.75%-16.64M | -557.58%-10.34M | -147.96%-688.62K | -63.73%2.37M |
| Net profit | -40.69%-59.51M | -152.07%-322.18M | -167.94%-190.25M | -154.25%-113.6M | -32.99%-42.3M | -425.59%-127.81M | -309.37%-71M | -323.12%-44.68M | -363.52%-31.81M | -27.65%39.26M |
| Net profit from continuing operation | -40.69%-59.51M | -152.07%-322.18M | -167.94%-190.25M | -154.25%-113.6M | -32.99%-42.3M | -425.59%-127.81M | -309.37%-71M | -323.12%-44.68M | -363.52%-31.81M | -27.65%39.26M |
| Less:Minority Profit | 74.35%-32.96K | -396.34%-369.35K | -607.36%-482.65K | -320.27%-257.08K | -104.65%-128.48K | --124.64K | --95.13K | --116.71K | ---62.78K | ---- |
| Net profit of parent company owners | -41.04%-59.48M | -151.54%-321.81M | -166.90%-189.77M | -153.01%-113.35M | -32.85%-42.17M | -425.90%-127.94M | -309.65%-71.1M | -323.70%-44.8M | -363.00%-31.74M | -27.65%39.26M |
| Earning per share | ||||||||||
| Basic earning per share | -39.39%-0.092 | -149.75%-0.497 | -163.96%-0.293 | -150.00%-0.175 | -33.33%-0.066 | -406.15%-0.199 | -294.74%-0.111 | -255.56%-0.07 | -261.24%-0.0495 | -52.90%0.065 |
| Diluted earning per share | -39.39%-0.092 | -149.75%-0.497 | -163.96%-0.293 | -150.00%-0.175 | -33.33%-0.066 | -406.15%-0.199 | -294.74%-0.111 | -255.56%-0.07 | -261.24%-0.0495 | -52.90%0.065 |
| Other composite income | 301.59%883.4K | -449.55%-1.3M | -266.74%-986.05K | -477.90%-2.45M | -263.77%-438.21K | 2,466,629.17%372.94K | 591.38K | 648.94K | -120.46K | -15.12 |
| Other composite income of parent company owners | 301.59%883.4K | -449.55%-1.3M | -266.74%-986.05K | -477.90%-2.45M | -263.77%-438.21K | 2,466,629.17%372.94K | --591.38K | --648.94K | ---120.46K | ---15.12 |
| Total composite income | -37.18%-58.63M | -153.83%-323.49M | -171.59%-191.24M | -163.57%-116.05M | -33.86%-42.74M | -424.64%-127.44M | -307.62%-70.41M | -319.88%-44.03M | -364.52%-31.93M | -27.65%39.26M |
| Total composite income of parent company owners | -37.52%-58.59M | -153.29%-323.12M | -170.54%-190.75M | -162.29%-115.8M | -33.72%-42.61M | -424.95%-127.57M | -307.90%-70.51M | -320.46%-44.15M | -364.00%-31.86M | -27.65%39.26M |
| Total composite income of minority owners | 74.35%-32.96K | -396.34%-369.35K | -607.36%-482.65K | -320.27%-257.08K | -104.65%-128.48K | --124.64K | --95.13K | --116.71K | ---62.78K | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.